◆SK Biopharm=Transfer of development and commercialization rights for the epilepsy drug Cenobamate in Japan
◆Cosmax=Patent rights related to compositions for strengthening the skin barrier, skin moisturizing, or anti-aging
◆Hanjin=Q3 operating profit of 27.6 billion KRW...7.4% increase year-on-year
◆KT Skylife=Acquisition of Hyundai HCN shares for 491.1 billion KRW
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
